Disrupting Virchow's triad: can factor X inhibition reduce risk of adverse outcomes in patients with ischaemic cardiomyopathy?

Journal article

Open access

Peer reviewed

Tariq Ahmad and Javed Butler

European journal of heart failure, Vol.17(7), pp.647-651

07/2015

PMID: 26018996

Abstract

Coronary Artery Disease - drug therapy

Factor Xa Inhibitors - therapeutic use

Heart Failure - drug therapy

Humans

Myocardial Infarction - prevention & control

Research Design

Rivaroxaban - therapeutic use

Stroke - prevention & control

url

https://doi.org/10.1002/ejhf.296View

Published (Version of record) Open

1 Record Views

Title: Disrupting Virchow's triad: can factor X inhibition reduce risk of adverse outcomes in patients with ischaemic cardiomyopathy?
Creators - without role: Tariq Ahmad - Yale University
Javed Butler - Stony Brook University
Publication Details: European journal of heart failure, Vol.17(7), pp.647-651
Identifiers: 9926113308331
Academic Unit: Prince Sattam Bin Abdulaziz University
Language: English
Resource Type: Journal article